...
首页> 外文期刊>Bioorganic and Medicinal Chemistry >Synthesis and in vitro evaluation of S-acyl-3-thiopropyl prodrugs of Foscarnet
【24h】

Synthesis and in vitro evaluation of S-acyl-3-thiopropyl prodrugs of Foscarnet

机译:膦甲酸的S-酰基-3-硫丙基的前药的合成与体外评价

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A new enzyme-labile group called S-acyl-3-thiopropyl group (SATP) has been synthesized from allylic esters of phos-phonate. After demonstration of the enzyme-labile character of the SATP in cellular extracts, it has been introduced onto the phosphonate moiety of PFA (Foscarnet) to obtain potential lipophilic prodrugs. To ponder the lipophilicity of the triesters of PFA, esters of monomethylether of polyethyleneglycols and of thioglycerol were introduced on the PFA carboxylate moiety. The SATP groups were introduced in an attempt to deliver PFA after bioactivation inside the cells. The PFA prodrugs were evaluated in vitro for their activity against human immunodeficiency viruses (HIV-1 and HIV-2).
机译:从膦酸酯的烯丙基酯合成了一个新的对酶不稳定的基团,称为S-酰基-3-硫丙基(SATP)。在证明细胞提取物中SATP的酶不稳定特性后,已将其引入PFA(膦酸酯)的膦酸酯部分中,以获得潜在的亲脂性前药。为了考虑PFA的三酯的亲脂性,将聚乙二醇的单甲基醚和硫代甘油的酯引入到PFA的羧酸酯部分上。引入SATP基团是为了在细胞内生物激活后递送PFA。在体外评估了PFA前药对人免疫缺陷病毒(HIV-1和HIV-2)的活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号